BioMarin Pharmaceutical (BMRN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

BMRN is expected to report earnings to fall 45.60% to 52 cents per share on October 23

BioMarin Pharmaceutical BMRN Stock Earnings Reports

Q3'24

Est.

$0.52

Q2'24

Beat

by $0.61

Q1'24

Beat

by $0.39

Q4'23

Beat

by $0.29

Q3'23

Beat

by $0.23

The last earnings report on August 05 showed earnings per share of 95 cents, beating the estimate of 34 cents. With 1.09M shares outstanding, the current market capitalization sits at 13.44B.

View a ticker or compare two or three

Compare

BMRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BMRN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BMRN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

770 Lindaro Street

Phone

+1 415 506-6700

Employees

3401

Web

https://www.biomarin.com